Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

China flag China · Delayed Price · Currency is CNY
71.66
+0.62 (0.87%)
At close: Dec 12, 2025
19.83%
Market Cap17.66B
Revenue (ttm)2.41B
Net Income (ttm)646.21M
Shares Out246.43M
EPS (ttm)2.63
PE Ratio27.29
Forward PEn/a
Dividend0.80 (1.12%)
Ex-Dividend DateSep 24, 2025
Volume9,604,890
Average Volume6,346,244
Open71.06
Previous Close71.04
Day's Range70.51 - 73.20
52-Week Range46.45 - 85.65
Beta0.41
RSI47.15
Earnings DateApr 19, 2026

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China. The company provides myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs, intraocular rinsing fluids, pupil dilatant and ciliary muscle paralyzers, anti-fatigue medicines, and dry eye medicines. It also engages in the techn... [Read more]

Sector Healthcare
Founded 1977
Employees 2,426
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300573
Full Company Profile

Financial Performance

In 2024, SHE:300573's revenue was 1.94 billion, an increase of 32.42% compared to the previous year's 1.47 billion. Earnings were 338.06 million, an increase of 40.84%.

Financial Statements

News

There is no news available yet.